Why is Aarey Drugs falling/rising?

As of 17-Sep, Aarey Drugs & Pharmaceuticals Ltd is currently priced at 71.69, reflecting a decline of 0.61, or 0.84%. The stock has underperformed its sector today by 1.62%, and while it remains above its 20-day, 50-day, 100-day, and 200-day moving averages, it is below its 5-day moving average. The stock has shown a mixed performance over different periods, with a 1-week decline of 1.46% and a 1-month increase of 10.62%. Despite generating a return of 5.40% over the past year, the company has faced challenges, including a significant drop in profits by 26.2% and a weak long-term fundamental strength indicated by a -45.90% CAGR growth in operating profits over the last five years. In the broader market context, the Sensex has increased by 1.56% over the past week, contrasting with Aarey Drugs' recent decline. The stock's liquidity remains adequate for trading, but a notable drop in delivery volume by 78.26% against the 5-day average suggests waning investor interest. Additionally, the company's weak ability to service its debt, as indicated by a poor EBIT to Interest ratio, and the reliance on non-operating income for profitability further contribute to the stock's downward pressure. Overall, while Aarey Drugs has shown consistent returns over the last three years, the recent negative financial results and declining operating profits are likely influencing the current price movement.